BeOne Medicines
ONC
#660
Rank
โ‚น3.168 T
Marketcap
โ‚น28,630
Share price
-2.39%
Change (1 day)
62.87%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น314.72 Billion

According to BeOne Medicines's latest financial reports the company's total liabilities are โ‚น314.72 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BeOne Medicines - Total liabilities on balance sheet (from 2014 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น222.07 B17.62%
2023-12-31โ‚น188.80 B14.31%
2022-12-31โ‚น165.16 B-7.66%
2021-12-31โ‚น178.85 B41.24%
2020-12-31โ‚น126.63 B180.12%
2019-12-31โ‚น45.20 B30.34%
2018-12-31โ‚น34.68 B49.95%
2017-12-31โ‚น23.12 B543.35%
2016-12-31โ‚น3.59 B27.46%
2015-12-31โ‚น2.82 B59.79%
2014-12-31โ‚น1.76 B-43.45%
2013-12-31โ‚น3.12 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Onconova Therapeutics
ONTX
โ‚น1.09 B-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚น61.98 B-80.30%๐Ÿ‡บ๐Ÿ‡ธ USA